Prevalence and Time of Diagnosis of Endometriosis across Racial and Ethnic Groups in the US

Introduction

Endometriosis is a chronic gynecological condition characterized by the presence of tissue with the histologic appearance of endometrial glands and stroma outside of the endometrial cavity, which often causes dysmenorrhea, dyspareunia, chronic pelvic pain, and is often associated with infertility (Howard, 2009). It is suggested to be prevalent in about 10% of women of reproductive age (Shafrir et al., 2018). With $12,118 direct cost and $15,737 indirect cost per patient per year, the economic toll of endometriosis is highest in the United States (US) (Ahmed M. Soliman, Yang, Du, Kelley, & Winkel, 2016). A few studies have estimated the prevalence of endometriosis among reproductive-aged women in the US, although these estimates may not be an accurate reflection of the nationwide prevalence due to study design limitations such as endometriosis assessment method and self-selection into online survey (Bernuit et al., 2011; Fuldeore & Soliman, 2017; Kjerulff, Erickson, & Langenberg, 1996). Importantly, the prevalence of endometriosis within various racial and ethnic groups in the US is still unknown despite the conclusion from a recent systematic review that Black and Hispanic women were less likely to be diagnosed with endometriosis than white women (Bougie, Yap, Sikora, Flaxman, & Singh, 2019).

Disparity in endometriosis diagnosis may contribute to the commonly believed and observed lower prevalence of endometriosis among nonwhite women. Such racial disparity could be due in part to socioeconomic factors such as access to health care, as the diagnosis of endometriosis is usually preceded by multiple clinical visits sometimes between numerous providers, and requires laparoscopic confirmation. Extant literature suggests that the delay from symptom onset to the diagnosis of endometriosis ranges from 4-11 years (Agarwal et al., 2019; Nnoaham et al., 2011; A. M. Soliman, Fuldeore, & Snabes, 2017), with significant delay even in countries with universal health care (Hudelist et al., 2012; Staal, van der Zanden, & Nap, 2016). In the US where the health care systems are largely segregated and the health care resources are unevenly distributed across different socioeconomic strata (Fiscella & Williams, 2004; Ko, Needleman Derose, Laugesen, & Ponce, 2014; Smith, 2005), women of different racial and ethnic backgrounds may face different levels of challenges on their path to the diagnosis of endometriosis. However, there has been little research in the experiences of the diagnosis of endometriosis in general, with even less research focusing on the experiences of racial and ethnic minorities

In addition to socioeconomic factors, diagnostic biases may also play a role in explaining for the racial disparity in the diagnosis. Endometriosis has historically been depicted as a disease of white and affluent women who tend to postpone childbearing and is believed to be rare among nonwhite women (Blinick & Merendino, 1951; Meigs, 1938; Scott & Te Linde, 1950). This notion originated from patient observations among clinics that mainly served patients with private insurance and/or white women (Blinick & Merendino, 1951; Gibson & Jung, 2005), and is bolstered by the prevalence data that suggest a lower prevalence of endometriosis among nonwhite women (Bougie, Yap, et al., 2019; Fuldeore & Soliman, 2017; Mowers et al., 2016; Nnoaham et al., 2011). However, these prevalence estimates only provide a snapshot view of endometriosis presence among populations and fail to take into account the diagnostic process. The prevailing notion of white predominance of the disease may perpetuate the diagnostic bias in medical professionals, which is evidenced by the observation that 40% of African-American women with a laparoscopic evidence of endometriosis were previously misdiagnosed with pelvic inflammatory disease (Chatman, 1976). To date, to what extent the seemingly lower prevalence of endometriosis among nonwhite women is attributed to potential diagnostic biases remains unknown, impeding the goal of early diagnosis and quality care of endometriosis among minority female populations.

To gain a better understanding of both the epidemiology and diagnosis of endometriosis across different racial and ethnic groups in the US, we estimated the race and ethnicity-specific prevalence of endometriosis among US women of reproductive age and further examined the association between race/ethnicity and the age of endometriosis diagnosis, using data from the National Health and Nutrition Examination Survey (NHANES). We examined this association by conditioning on socioeconomic, lifestyle, and reproductive characteristics, so that the difference found across racial and ethnic groups in the age of diagnosis could potentially reflect racially and/or ethnically-related diagnostic biases for endometriosis.

Methods

Results

The flowchart for sample selection is presented in Figure 1. Out of 41,474 NHANES participants 1999–2006, 6,508 were women aged 20-54 years and 95.4% of them completed the reproductive health questionnaire among whom 89.5% had information regarding whether they had been diagnosed of endometriosis. From 1999–2006, the prevalence of endometriosis ranged between 8.1% and 9.4% (Table 1), with a pooled prevalence of 9.0%. The prevalence was highest among non-Hispanic white women (11.1%) and lowest among Hispanic women (2.7%).

• Download figure
• Open in new tab

Figure 1.

Flowchart for sample selection

Among the 380 women who reported having a diagnosis of endometriosis, age of diagnosis was available for 375 of them. As shown in Table 2, the mean age of diagnosis was 29 years. A later diagnosis of endometriosis was seen among black and Hispanic women, women with a high school degree, women without health insurance, women with family income below the poverty line, women who did not smoke and who had a higher BMI, women who had a later age of menarche, who were parous and who reported the longest duration of birth control pills use prior to the diagnosis of endometriosis.

Adjusting for socioeconomic, lifestyle, and reproductive factors, there was a statistically significant difference in the age of endometriosis diagnosis across different racial and ethnic groups (Table 3). Compared with non-Hispanic white women, non-Hispanic black women were on average diagnosed of endometriosis 2.62 years later and Hispanic women were diagnosed 3.85 years later. Women identifying as “Other” were diagnosed slightly earlier but the difference was not significant. In this adjusted model, income-to-poverty ratio, being parous, and years on birth control pills were also significant predictors of age of endometriosis diagnosis. Particularly, parous women were diagnosed of endometriosis 7 years later than nulliparous women.

Discussion

In this large, nationally representative sample of US women of reproductive age surveyed between 1999-2006, the prevalence of self-reported diagnosis of endometriosis was 9.0%, consistent with the commonly quoted 10% prevalence. The prevalence was highest among non-Hispanic white women and lowest among Hispanic women. Accounting for socioeconomic, lifestyle, and reproductive characteristics, non-Hispanic women were diagnosed with endometriosis at 2.6 years older, and Hispanic women at 3.8 years older, compared with non-Hispanic white women.

This study is among the few to estimate the prevalence of endometriosis in the US. Our national prevalence estimate of 9% is higher than the 12-month prevalence of 6.9% reported by Kjenilff et al using data from the National Health Interview Survey 1984-1992 (Kjerulff et al., 1996). Two online surveys conducted in 2009 and 2012 among the US women aged 18-49 reported the prevalence of endometriosis to be 6.6%–10.8% (Bernuit et al., 2011) and 6.1% (Fuldeore & Soliman, 2017), respectively. However, the selected participants only represented 74% of the target US population in the first study and neither study addressed selection bias due to the nature of online surveys. Our prevalence was estimated from a nationally representative sample which is less subject to selection bias.

This study is the first to describe the national prevalence of endometriosis by different racial and ethnic groups in the US. Non-Hispanic white women had twice the prevalence compared to non-Hispanic black women. The prevalence estimate among Hispanic women in our study (2.7%) was lower than the reported 4% among Puerto Rican women (Flores et al., 2008). This may be due to different sampling methods (complex, multistage, probability sampling in ours vs convenient sampling in the latter) and different population characteristics (predominantly Mexican American women in ours vs Puerto Rican women in the latter).

Beyond confirming a higher prevalence of endometriosis among non-Hispanic white women compared with non-Hispanic Black and Hispanic women, our study makes a significant contribution by revealing, for the first time, the gaps in the age of endometriosis diagnosis across different racial and ethnic groups, potentially reflecting the racially and ethnically-related diagnostic biases of endometriosis. Different racial and ethnic groups may have different risks of developing endometriosis as suggested by a prospective cohort study (Missmer et al., 2004), and such difference could be due to genetic, lifestyle, and reproductive factors (Shafrir et al., 2018). The association between socioeconomic factors and endometriosis may be more complex, as these factors may influence both endometriosis incidence and access to health care. An earlier diagnosis of endometriosis among those with health care access does not mean an earlier onset of endometriosis. Our findings, after conditioning on socioeconomic, lifestyle, and reproductive factors, demonstrated a 2.6 and 3.8 years’ difference in the age of endometriosis diagnosis for black and Hispanic women relative to white women, respectively. This difference could be due to a true late onset of endometriosis among black and Hispanic women, different symptoms or clinical presentations of endometriosis among these women, or potentially biases among health care providers making the diagnosis (Bougie, Healey, & Singh, 2019). Since we controlled for the most established risk factors of endometriosis (i.e., BMI, age of menarche, parity, birth control pills use), as well as socioeconomic factors (including health insurance as an indicator of health care access), we believe that the observed gap in the age of endometriosis diagnosis partly reflects race/ethnicity-associated diagnostic biases.

Endometriosis in women is associated with substantial negative health, developmental (e.g., pursuing education and career choices, starting a family), occupational, and relational impact across the lifespan (Missmer et al., 2021), but many women experience significant delay in receiving the diagnosis. According to a recent online survey of women with endometriosis, more than half waited 6 or more years for the diagnosis of endometriosis while 54.3% experienced endometriosis-related pain daily (Lamvu, Antunez-Flores, Orady, & Schneider, 2020). The delay in the diagnosis has been reported to occur at both the individual patient level and the medical community level (Ballard, Lowton, & Wright, 2006). For example, it is very common for women to normalize and accommodate their menstrual pain which is usually the first symptom of endometriosis. At the medical level, there is a significant delay in referral from primary to secondary care which may be associated with pain normalized by family doctors. Intermittent hormonal suppression of symptoms as well as the use of nondiscriminatory diagnostic tools further contribute to the delay (Ballard et al., 2006). Relating to the discrepancy in the age of endometriosis diagnosis across different racial and ethnic groups found in our study, there could be a greater degree of normalization of menstrual symptoms among black and Hispanic women themselves as well as medical professionals in treating these patients. Additionally, due to the commonly held belief that endometriosis is less common among nonwhite women, providers may be less likely to associate symptoms in black and Hispanic women with endometriosis, and therefore, less likely to make a timely and proper referral.

Limitations for the present study must be noted. First, we were not able to conclude definitely whether the observed differences in the age of endometriosis diagnosis were due to different disease/symptom onset or delay in diagnosis, although we controlled for common risk factors of endometriosis. Future research is needed to examine the duration from symptom onset to a confirmatory clinical diagnosis of endometriosis across various racial and ethnic groups to delineate the diagnostic disparity that could be avoided. Second, we were not able to ascertain the diagnostic method (e.g., histologically proven, surgical, clinical suspicion) and presenting symptoms (e.g., with or without pain, with or without infertility) of endometriosis. It is possible that black and Hispanic women were diagnosed with endometriosis by chance at older ages.

Future research should identify and focus on the clinical meaningful phenotypes of endometriosis that are relevant to women of different racial and ethnic background. Third, for hormonal contraceptives, we only controlled for birth control pills use which was the only type of contraceptive that we were able to ascertain the length of use prior to the diagnosis of endometriosis, which may cause residual confounding. Fourth, we analyzed the NHANES 1999-2006 data. Over the years there has been an increasing awareness of endometriosis in the medical field and the society. More research is needed to determine whether the gap in the age of endometriosis diagnosis persists across different racial and ethnic groups, and if so, whether factors contributing to this diagnostic disparity change over time.

Conclusions

Self-reported endometriosis was prevalent in 9% of reproductive-aged US women between 1999 and 2006. Black and Hispanic women had lower prevalence of endometriosis, and were diagnosed with endometriosis at later ages, compared with their white counterparts. This later diagnosis was observed after accounting for factors associated with the risk of and access to care for endometriosis, which potentially reflects the diagnostic biases related to race and ethnicity.